The pharmaceutical community is intrigued by retatrutide, a novel dual GIP and GLP-1 agonist that’s showing remarkable results in clinical research. This treatment works by replicating natural hormones to regulate appetite and boost feelings of satisfaction , ultimately contributing to considerable body reduction . While currently under investiga